Transcatheter edge-to-edge repair (TEER) is feasible and clinically beneficial for treating tricuspid regurgitation in selected patients with repaired tetralogy of Fallot.
Is transcatheter tricuspid valve edge-to-edge repair feasible and clinically beneficial in patients with repaired Tetralogy of Fallot and tricuspid regurgitation?
Transcatheter tricuspid edge-to-edge repair is a feasible and clinically beneficial option for managing tricuspid regurgitation in selected patients with repaired Tetralogy of Fallot.
Absolute Event Rate: 0% vs 0%
TR contributes to right heart failure in rTOF. The tricuspid subvalvular apparatus may be fragile; nevertheless, TEER remains feasible and clinically beneficial in selected patients.
Azizi et al. (Sun,) reported a other. Transcatheter edge-to-edge repair (TEER) is feasible and clinically beneficial for treating tricuspid regurgitation in selected patients with repaired tetralogy of Fallot.